GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kee Song Bio-Technology Holdings Ltd (ROCO:1258) » Definitions » Equity-to-Asset

Kee Song Bio-Technology Holdings (ROCO:1258) Equity-to-Asset : 0.33 (As of Mar. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Kee Song Bio-Technology Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Kee Song Bio-Technology Holdings's Total Stockholders Equity for the quarter that ended in Mar. 2023 was NT$758 Mil. Kee Song Bio-Technology Holdings's Total Assets for the quarter that ended in Mar. 2023 was NT$2,267 Mil. Therefore, Kee Song Bio-Technology Holdings's Equity to Asset Ratio for the quarter that ended in Mar. 2023 was 0.33.

The historical rank and industry rank for Kee Song Bio-Technology Holdings's Equity-to-Asset or its related term are showing as below:

ROCO:1258's Equity-to-Asset is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 0.54
* Ranked among companies with meaningful Equity-to-Asset only.

Kee Song Bio-Technology Holdings Equity-to-Asset Historical Data

The historical data trend for Kee Song Bio-Technology Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kee Song Bio-Technology Holdings Equity-to-Asset Chart

Kee Song Bio-Technology Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.21 0.21 0.26 0.30

Kee Song Bio-Technology Holdings Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.30 0.29 0.30 0.33

Competitive Comparison of Kee Song Bio-Technology Holdings's Equity-to-Asset

For the Packaged Foods subindustry, Kee Song Bio-Technology Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kee Song Bio-Technology Holdings's Equity-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kee Song Bio-Technology Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Kee Song Bio-Technology Holdings's Equity-to-Asset falls into.



Kee Song Bio-Technology Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Kee Song Bio-Technology Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )=Total Stockholders Equity/Total Assets
=708.17/2341.95
=0.30

Kee Song Bio-Technology Holdings's Equity to Asset Ratio for the quarter that ended in Mar. 2023 is calculated as

Equity to Asset (Q: Mar. 2023 )=Total Stockholders Equity/Total Assets
=757.79/2266.869
=0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kee Song Bio-Technology Holdings  (ROCO:1258) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Kee Song Bio-Technology Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Kee Song Bio-Technology Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Kee Song Bio-Technology Holdings (ROCO:1258) Business Description

Traded in Other Exchanges
N/A
Address
Songjiang Road, 104, 8th Floor, No. 51, Zhongshan District, Taipei, TWN, 104
Kee Song Bio-Technology Holdings Ltd is engaged in the processing and distribution of meat products. This includes poultry, production, and sale of chicken as well as the trade of frozen meat and prepared food. It has two reportable segments; the Poultry and processing distribution segment which is engaged in the business of importing, slaughtering, wholesaling, and retailing poultry and consumable goods of all kinds; and the Poultry farming segment involved in the business of poultry farming. It derives a majority of its revenue from the poultry farming segment.

Kee Song Bio-Technology Holdings (ROCO:1258) Headlines

No Headlines